CAL101

idelalisib · Calluna Pharma AS

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CAL101, covering 2026-03-13 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]